Utility of patch testing for the diagnosis of delayed-type drug hypersensitivity reactions to clindamycin
- 1 September 2020
- journal article
- editorial
- Published by Wiley in Contact Dermatitis
- Vol. 83 (3), 237-+
- https://doi.org/10.1111/cod.13575
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Patch testing for nonimmediate cutaneous adverse drug reactionsJournal of the American Academy of Dermatology, 2018
- Generalized reactions during skin testing with clindamycin in drug hypersensitivity: a report of 3 cases and review of the literatureContact Dermatitis, 2018
- Long‐term reproducibility of positive patch test reactions in patients with non‐immediate cutaneous adverse drug reactions to antibioticsContact Dermatitis, 2016
- Patch testing – a valuable tool for investigating non‐immediate cutaneous adverse drug reactions to antibioticsJournal of the European Academy of Dermatology and Venereology, 2016
- Drug‐induced skin reaction elicited by clindamycin and penicillin: one rash, but two culpritsClinical and Translational Allergy, 2014
- Utility of patch testing for patients with drug eruptionClinical and Experimental Dermatology, 2014
- Multiple drug hypersensitivity syndromeCurrent Opinion in Allergy and Clinical Immunology, 2013
- Value of patch tests in clindamycin-related drug eruptionsContact Dermatitis, 2011
- Clindamycin skin testing has limited diagnostic potentialContact Dermatitis, 2005
- Guidelines for performing skin tests withdrugs in the investigation of cutaneous adverse drug reactionsContact Dermatitis, 2001